We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current UPR market cap is 562.41M. The company's latest EPS is EUR 0.1641 and P/E is 12.55.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.67B | 1.82B | 1.94B | 2.07B | 2.55B |
| Operating Income | 28.15M | 39.32M | 45.92M | 53.97M | 68.74M |
| Net Income | 21.03M | 27.83M | 48.08M | 45.59M | 44.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 761.35M | 840.46M | 944.99M | 1.11B | 1.29B |
| Total Liabilities | 580.43M | 637.92M | 693.43M | 821.01M | 955.94M |
| Total Equity | 180.92M | 202.54M | 251.56M | 289.78M | 333.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 107M | 65.98M | 52.18M | 82.83M | 52.51M |
| Investing | -45.64M | -110.33M | -49.66M | -106.33M | -90.43M |
| Financing | 42.15M | -8.72M | 13.26M | 50.41M | 19.63M |
| Market Cap | 562.41M |
| Price to Earnings Ratio | 12.55 |
| Price to Sales Ratio | 0.22 |
| Price to Cash Ratio | 6.57 |
| Price to Book Ratio | 1.69 |
| Dividend Yield | 1.08% |
| Shares Outstanding | 273.02M |
| Average Volume (1 week) | 86.16k |
| Average Volume (1 Month) | 44.76k |
| 52 Week Change | -14.17% |
| 52 Week High | 246.00 |
| 52 Week Low | 165.00 |
| Spread (Intraday) | 4 (1.92%) |
| Company Name | Uniphar Plc |
| Address |
4045 kingswood road dublin D24 VO6K |
| Website | https://www.uniphar.ie |
| Industry | drug & proprietary stores (5912) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
